20096 ⎘
Medicinal preparations characterised by special physical form; Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Delivery devices for modulating inflammation
#3602Anti-inflammatory compositions and methods
#3603Formulations of single domain antigen binding molecules
#3604METHODS AND COMPOSITIONS FOR INTRA-ARTICULAR COAGULATION PROTEINS
#3605LYOPHILIZED ANTI-FUNGAL COMPOSITION
#3606Composition and microsphere for controlled-release of exendin, and method preparing the same
#3607Systems for modulating inflammation
#3608Systems for modulating inflammation
#3609Systems for modulating inflammation
#3610Systems for modulating inflammation
#3611STABILIZED SUSPENSION
#3612Delivery devices for modulating inflammation
#3613USE OF ROSMARINIC ACID IN MANUFACTURE OF MEDICAMENTS FOR TREATING OR PREVENTING HEPATIC AND RENAL DISEASES
#3614SUSTAINED-RELEASE NANOPARTICLE CONTAINING LOW-MOLECULAR-WEIGHT DRUG WITH NEGATIVELY CHARGED GROUP
#3615NOVEL PHARMACEUTICAL COMPOSITION
#3616Parenteral formulations comprising sugar-based esters and ethers
#3617Stabilizing alkylglycoside compositions and methods thereof
#3618Frozen compositions and methods for piercing a substrate
#3619HIGHLY CONCENTRATED INSULIN SOLUTIONS AND COMPOSITIONS
#3620Frozen compositions and array devices thereof
#3621Compositions and methods for biological remodeling with frozen particle compositions
#3622Frozen compositions and methods for piercing a substrate
#3623Compositions and methods for delivery of frozen particle adhesives
#3624Compositions and methods for delivery of frozen particle adhesives
#3625Compositions and methods for therapeutic delivery with frozen particles
#3626Compositions and methods for biological remodeling with frozen particle compositions
#3627Compositions and methods for biological remodeling with frozen particle compositions
#3628Endoxifen compositions and methods
#3629Compositions and methods for surface abrasion with frozen particles
#3630Frozen piercing implements and methods for piercing a substrate
#3631Frozen compositions and methods for piercing a substrate
#3632Compositions and methods for administering compartmentalized frozen particles
#3633Compositions and methods for administering compartmentalized frozen particles
#3634Compositions and methods for delivery of frozen particle adhesives
#3635Compositions and methods for therapeutic delivery with frozen particles
#3636Compositions and methods for therapeutic delivery with frozen particles
#3637Compositions and methods for therapeutic delivery with frozen particles
#3638Compositions and methods for therapeutic delivery with frozen particles
#3639Compositions and methods for surface abrasion with frozen particles
#3640Compositions and methods for biological remodeling with frozen particle compositions
#3641Compositions and methods for therapeutic delivery with frozen particles
#3642Compositions and methods for therapeutic delivery with frozen particles
#3643Compositions and methods for therapeutic delivery with frozen particles
#3644Compositions and methods for surface abrasion with frozen particles
#3645Therapeutic polymeric nanoparticles comprising vinca alkaloids and methods of making and using same
#3646Stable aqueous G-CSF formulations
#3647BIODEGRADABLE COMPOSITIONS AND MATERIALS
#3648Lyophilized preparation comprising influenza vaccine, and method for preparation thereof
#3649LYOPHILIZED RECOMBINANT VWF FORMULATIONS
#3650DRUG DELIVERY SYSTEMS AND METHODS FOR TREATING NEOVASCULARIZATION
#3651Freeze-dried injectable pharmaceutical combination of semisynthetic vinca alkaloids and carbohydrate stable at room temperature
#3652Modified calcium phosphate nanoparticle formation
#3653Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin
#3654LYOPHILIZED PHARMACEUTICAL COMPOSITIONS AND METHODS OF MAKING AND USING SAME
#3655Solid betalain compositions and methods
#3656Lyophilized VEGF antagonist formulations for intravitreal administration
#3657NOVEL ANTIBODY FORMULATION
#3658Formulations of PEG-interferon alpha conjugates
#3659Gel useful for the delivery of ophthalmic drugs
#3660Therapeutic polymeric nanoparticles with mTor inhibitors and methods of making and using same
#3661Drug loaded polymeric nanoparticles and methods of making and using same
#3662Drug loaded polymeric nanoparticles and methods of making and using same
#3663Preparation of pharmaceutical compositions
#3664Methods and compositions for tissue regeneration
#3665STARCH-BASED MICROPARTICLES FOR THE RELEASE OF AGENTS DISPOSED THEREIN
#3666Aqueous Systems For The Preparation Of Lipid Based Pharmaceutical Compounds; Compositions, Methods, And Uses Thereof
#3667Method of micronization
#3668Formulations of Tetrahydropyridine Antiplatelet Agents for Parenteral or Oral Administration
#3669Formulations of canfosfamide and their preparation
#3670Stable Parenteral Formulation
#3671Absorption enhancers such as E.G. BHT, BHA or propyl gallate
#3672Stable lyophilized pharmaceutical formulation of IgG antibodies
#3673CRYSTALLINE FORMS OF A BIPHENYL COMPOUND
#3674FORMULATIONS COMPRISING PALONOSETRON
#36753'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene] hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
#36763′-[(2Z)-[1-(3,4-dimethylphenyl)-1 ,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
#36773′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene] hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
#3678Lyophilization above collapse
#3679Use of Amphiphilic Biocompatible Polymers for Solubilization of Hydrophobic Drugs
#36803′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
#36813′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
#3682Freeze-dried composition of inactivated virus envelope with membrane fusion activity
#3683NOVEL FORMULATIONS OF PHARMACOLOGICAL AGENTS, METHODS FOR THE PREPARATION THEREOF AND METHODS FOR THE USE THEREOF
#3684Toll-like receptor agonist formulations and their use
#3685Pharmaceutical formulation
#3686SILK MICROSPHERES FOR ENCAPSULATION AND CONTROLLED RELEASE
#3687Pharmaceutical Compositions and Methods for Treating or Preventing Oxalate-Related Disease
#3688Chemically defined vaccine stabiliser
#3689METHODS AND COMPOSITIONS FOR DELIVERY OF EXOGENOUS FACTORS TO NERVOUS SYSTEM SITES
#3690Crystalline forms of a biphenyl compound
#3691anti-parasitic compositions
#3692Pharmaceutical compositions
#3693DRIED ELECTRIFIED HYDROCOLLOID GELS HAVING UNIQUE STRUCTURE AND POROSITY
#3694Pharmaceutical composition for treatment of diseases associated with decrease in bone mass comprising EP4 agonist as active ingredient
#3695LYOPHILIZED PREPARATION OF 1-METHYLCARBAPENEM
#3696SUBMICRON NANOPARTICLE OF POORLY WATER SOLUBLE CAMPTOTHECIN DERIVATIVES AND PROCESS FOR PREPARATION THEREOF
#3697Processes for preparing pharmaceutical compositions
#3698PHARMACEUTICAL COMPOSITIONS FOR THE ORAL OR RECTAL ADMINISTRATION OF PROTEIN SUBSTANCES
#3699STABILIZING ALKYLGLYCOSIDE COMPOSITIONS AND METHODS THEREOF
#3700Preparation of pharmaceutical formulations
#3701STABLE LYOPHILIZED PREPARATION
#3702Dry wound dressing and drug delivery system
#3703PULMONARY DRUG DELIVERY
#3704PEG-MODIFIED HYDROXYAPATITE, PHARMACEUTICAL USING THE SAME AS BASE MATERIAL AND PRODUCTION PROCESS THEREOF
#3705Methods and kits for treating joints and soft tissues
#3706Albumin-Free Botulinum Toxin Based Pharmaceutical Compositions Containing a Hyaluronidase and Methods of Use
#3707Chitin micro-particles as an adjuvant
#3708Nanoparticles containing water-soluble non-peptide low-molecular weight drug
#3709Antibody Formulation
#3710Compositions for the in vivo delivery of RNAi agents
#3711Stabilized Parathyroid Hormone Composition Comprising Parathyroid Hormone, Buffer and Stabilizing Agent
#3712Stabilizing alkylglycoside compositions and methods thereof
#3713Multimer of extracellular domain of cell surface functional molecule
#3714Pharmaceutical compositions
#3715CLOSTRIDIAL TOXIN PHARMACEUTICAL COMPOSITIONS
#3716Stabilized pharmaceutical formulations that contain the interferons gammas and alpha in synergistic proportions
#3717Magnet-field controlled active substance transfer for aerosol therapy
#3718METHODS OF TREATING VIRAL INFECTIONS WITH ANTHRACYCLINE ANTIBIOTICS
#3719Stable liquid formulation of human growth hormone
#3720HYDROPHOBIC COMPOSITIONS CONTAINING RECONSTITUTION ENHANCER
#3721AGENT FOR TREATING EYE DISEASES
#3722SPINAL NUCLEUS PULPOSUS IMPLANT
#3723Chitosan-containing protective composition
#3724ENDOXIFEN METHODS AND COMPOSITIONS IN THE TREATMENT OF PSYCHIATRIC AND NEURODEGENERATIVE DISEASES
#3725Stabilized antibody-containing formulations
#3726Antibody formulations and methods of making same
#3727Antibiotic Formulations, Unit Doses, Kits, and Methods
#3728SiRNA-mediated inhibition of doublecortin and Ca2+/calmodulin-dependent kinase-like-1
#3729Dried reconstituted vesicle formation for pharmaceutical application
#3730Therapeutic formulation
#3731CLOSTRIDIUM BOTULINUM C3 EXOTRANSFERASE COMPOSITIONS AND METHODS FOR TREATING TUMOUR SPREADING
#3732Stable parenteral formulations of tigecycline
#3733Rehydratable pharmaceutical product
#3734RECONSTITUTABLE MICROSPHERE COMPOSITIONS USEFUL AS ULTRASONIC CONTRAST AGENTS
#3735Unit Dose Form of Glufosfamide
#3736Methods of administering porcine B-domainless fVIII
#3737NOVEL SOLID FORMS OF BENDAMUSTINE HYDROCHLORIDE
#3738Polylactide nanoparticles
#3739NANOPARTICLE FORMULATIONS AND USES THEREOF
#3740OLIGONUCLEOTIDES-TRANSFERRING PREPARATIONS
#3741COMPOSITIONS AND METHODS FOR PH TARGETED DRUG DELIVERY
#3742Lyophilized therapeutic peptibody formulations
#3743Anti-TNF antibodies, compositions, methods and uses
#3744Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
#3745Biocidal compositions
#3746ANTI-MAdCAM ANTIBODY COMPOSITIONS
#3747NICOTINE-CARRIER VACCINE FORMULATION
#3748HGF preparation
#3749Process for stabilizing an adjuvant containing vaccine composition
#3750Methods and compositions for tissue regeneration
#3751STABLE PHARMACEUTICAL COMPOSITIONS OF 5, 10 METHYLENETRAHYDROFOLATE
#3752Liposomal drug delivery constructs targeted by lipid-conjugated peptide ligands
#3753Pharmaceutical formulation comprising taxane, a solid composition of taxane, a process for preparing said solid composition of taxane, a solubilizing composition of said solid composition of taxane, and a kit for the injectable formulation of taxane
#3754LYOPHILIZED SOLID TAXANE COMPOSITION, A PROCESS FOR PREPARING SAID SOLID COMPOSITION, A PHARMACEUTICAL FORMULATION AND A KIT FOR SAID FORMULATION
#3755Solid Formulations
#3756Use of atp for the manufacture of a medicament for the prevention and treatment of oxidative stress and related conditions
#3757Pharmaceutical compositions containing sc(Fv)2
#3758PHARMACEUTICAL COMPOSITION FOR ADMINISTRATION BY INJECTION
#3759Lyophilized Immunoglobulin Formulations and Methods of Preparation
#3760COMPOSITIONS AND METHODS FOR DELIVERY OF SOLUTION TO THE SKIN
#3761ORGANIC COMPOUNDS
#3762Nanoparticles for protein drug delivery
#3763POLYMER-STABILIZED LIPOSOMAL COMPOSITIONS AND METHODS OF USE
#3764Pharmaceutical Composition and Dressing for Treating Skin Lesion, as Well as the Use of Cerium Salt Associated With a Collagen Matrix
#3765Stabilizing alkylglycoside compositions and methods thereof
#3766Compositions and methods for preparation of poorly water soluble drugs with increased stability
#3767Supplementary Food Composition For Reducing Body Odor
#3768Lyophilization Process
#3769Method of producing S-adenosyl-L-methionine-containing dry yeast having excellent storage stability, the product thereof and composition for oral intake
#3770HYDROXYETHYL STARCH-CONTAINING POLYPEPTIDE COMPOSITIONS
#3771Method for Freeze-Drying Nucleic Acid/Block Copolymer/Cationic Surfactant Complexes
#3772Stabilised compositions of factor VII polypeptides
#3773Propellant-based nanoparticulate dry powder aerosols and method of making
#3774Pharmaceutical formulations of antineoplastic agents
#3775Nanodispersions
#3776Caspofungin formulations
#3777Parenteral formulations of peptides for the treatment of systemic lupus erythematosus
#3778Stable pharmaceutical composition containing docetaxel and a method of manufacturing the same
#3779SULFO-POLYMER POWDER AND SULFO-POLYMER POWDER BLENDS WITH CARRIERS AND/OR ADDITIVES
#3780Room Temperature Stable, Lyophilized Natriuretic Peptide Formulations
#3781ANTIBODY FORMULATION
#3782Recombinant elastase proteins and methods of manufacturing and use thereof
#3783STABLE GALENIC FREEZE-DRIED PHARMACEUTICAL PREPARATION OF RECOMBINANT CARBOHYDRATE-BINDING POLYPEPTIDES
#3784STABLE PHARMACEUTICAL COMPOSITION COMPRISING BETA-LACTAM ANTIBIOTIC AND BUFFER
#3785STABLE PHARMACEUTICAL COMPOSITIONS OF AMINOGLYCOSIDE ANTIBIOTICS, ION-CHELATING AGENTS, AND BUFFERS
#3786Stable pharmaceutical composition comprising beta-lactam antibiotic and ion-chelating agent
#3787Nanoparticles for protein drug delivery
#3788Solid Vaccine Formulation
#3789Dried blood factor composition comprising trehalose
#3790Controlled release implantable dispensing device and method
#3791Methods for Preventing or Treating Complications of Airway Control Devices
#3792Nanoparticles for protein drug delivery
#3793Microparticles, microparticle dispersion and method and apparatus for producing the same
#3794Drug conjugate composition
#3795COMPOSITIONS AND METHODS FOR TREATING TUMOUR SPREADING
#3796Intermolecular Association Complex of a Carrier and of an Active Principle
#3797Stable pharmaceutical composition of rabeprazole
#3798Micelles
#3799Freeze-Dried Product for Introducing Nucleic Acid, Oligonucleic Acid or Derivative Thereof
#3800Composition for the Treatment of Diabetic Periodontitis
#3801Homogeneous attenuated human rotavirus population
#3802Anti-CTLA-4 antibody compositions
#3803Dry powder inhalation system for transpulmonary administration
#3804SUSTAINED RELEASE PHARMACEUTICAL COMPOSITIONS
#3805Implantable Drug Depot for Intrathecal Drug Delivery System for Pain Management
#3806Stabilizer for protein preparation comprising meglumine and use thereof
#3807Injectable meclizine formulations and methods
#3808Anti-M-CSF Antibody Compositions
#3809Technology for the Preparation of Microparticles
#3810Mucoadhesive Tetracycline Formulations
#3811Dry powder inhalation system for transpulmonary administration
#3812Co-Solvent Compositions and Methods for Improved Delivery of Dantrolene Therapeutic Agents
#3813Freeze-dried pantoprazole preparation and pantoprazole injection
#3814Sustained Delivery Formulations of Octreotide Compounds
#3815Epoprostenol formulation and method of making thereof
#3816Prosaposin as a neurotrophic factor
#3817Desiccated Biologics And Methods Of Preparing The Same
#3818Pharmaceutical composition containing gelling agent
#3819Anti-TNF antibodies, compositions, methods and uses
#3820Medical Compositions for Intravesical Treatment of Bladder Cancer
#3821Formulations comprising jorumycin-, renieramycin-, safracin- or saframycin-related compounds for treating proliferative diseases
#3822Anti-TNF antibodies, compositions, methods and uses
#3823GROWTH FACTOR FRACTION COMPOSITIONS AND METHODS
#3824Parenteral formulation for epothilone analogs
#3825METHOD FOR PRODUCING A NUCLEIC-ACID-CONTAINING COMPLEX PREPARATION
#3826Controlled release interferon drug products and treatment of HCV infections using same
#3827Pharmaceutical formulation of an antibody against IL13Ralpha1
#3828COMPOUNDS AND METHODS FOR ENHANCING SOLUBILITY OF FLORFENICOL AND STRUCTURALLY-RELATED ANTIBIOTICS USING CYCLODEXTRINS
#3829Pharmaceutical Products
#3830Modified starch material of biocompatible hemostasis
#3831Anti-IL-13 antibody formulations and uses thereof
#3832High temperature stable peptide formulation
#3833Forming Embolic Particles
#3834Treatment of macular degeneration with ADP-ribosyl transferase fusion protein therapeutic compositions
#3835Alphavirus and Alphavirus Replicon Particle Formulations and Methods
#3836Therapeutic formulation
#3837NOVEL IV FORMULATION OF TIPIFARNIB
#3838Nucleic Acid-Lipopolymer Compositions
#3839Composition, method of preparation & application of concentrated formulations of condensed nucleic acids with a cationic lipopolymer
#3840Compositions of specific binding agents to hepatocyte growth factor
#3841Compositions and Methods for Microbe Storage and Delivery
#3842DRY PLATELET COMPOSITION
#3843Crystal of Salt of Benzimidazole Compound
#3844Composition and Method of Use for Soft Tissue Augmentation/Drug Delivery
#3845Compositions and Methods for Promoting the Healing of Tissue of Multicellular Organisms
#3846INJECTABLE, NONAQUEOUS SUSPENSION WITH HIGH CONCENTRATION OF THERAPEUTIC AGENT
#3847INTRAVENOUS FORMULATIONS OF PYRIDOXAL 5'- PHOSPHATE AND METHOD OF PREPARATION
#3848FORMULATIONS FOR AMYLIN AGONIST PEPTIDES
#3849Human papillomavirus vaccine for oral administration
#3850Nanoparticles for protein drug delivery
#3851Manufacturing process for liposomal preparations
#3852Nanoparticles for protein drug delivery
#3853Solubilized formulation of docetaxel without tween 80
#3854Stabilized pharmaceutical peptide compositions
#3855Glycopeptide phosphonate derivatives
#3856Alpha 1-Antitrypsin Compositions and Treatment Methods Using Such Compositions
#3857Stabilized thrombin compositions
#3858Pharmaceutical compositions comprising docetaxel and methods for preparation thereof
#3859INJECTABLE DEPOT FORMULATIONS AND METHODS FOR PROVIDING SUSTAINED RELEASE OF NANOPARTICLE COMPOSITIONS
#3860Method for production of quinolone-containing lyophilized preparation
#3861METHODS AND FORMULATIONS FOR TOPICAL GENE THERAPY
#3862Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition
#3863Stable aqueous solutions of granulocyte macrophage colony-stimulating factor
#3864BONE TARGETING OF DEGRADABLE DRUG FILLED NANOPARTICLES
#3865Hypercompressed polymer particles for controlled release ophthalmic medications
#3866PHARMACEUTICAL COMPOSITIONS COMPRISING A POORLY WATER-SOLUBLE ACTIVE INGREDIENT, A SURFACTANT AND A WATER-SOLUBLE POLYMER
#3867Cell fusion promoter and utilization of the same
#3868Parenteral formulations of a peptide for the treatment of systemic lupus erythematosus
#3869Prosaposin as a neurotrophic factor
#3870Method for Preparing Sustained-Release Microparticles Comprising Sucrose Acetate Isobutyrate
#3871Stable lyophilized pharmaceutical preparations of monoclonal or polyclonal antibodies
#3872Encapsulated amyloid-beta peptides
#3873LYOPHILIZED FORMULATION
#3874Process for forming amorphous atorvastatin
#3875Stabilizing alkylglycoside compositions and methods thereof
#3876Lyophilization of virosomes
#3877Ultrasonic cancer treatment enhancer and cell killer
#3878Pharmaceutical Compositions
#3879Delivery System For Bioactive Agents on the Basis of a Polymeric Drug Carrier Comprising an Amphiphilic Block Polymer and a Polylacticacid Derivative
#3880Oral dosage formulations of protease-resistant polypeptides
#3881Sterile suspensions of slightly soluble basic peptide complexes and pharmaceutical formulations containing them
#3882PHARMACEUTICAL FORMULATIONS OF GHRH MOLECULES
#3883Polysaccharide microparticles containing biological agents: their preparation and applications
#3884SMALL PARTICLE LIPOSOME AEROSOLS FOR DELIVERY OF ANTI-CANCER DRUGS
#3885Formulations of water insoluble or poorly water soluble drugs in lipidated glycosaminoglycan particles and their use for diagnostic and therapy
#3886Platform Antibody Compositions
#3887Animal Medicament and Method of Manufacture
#3888Advanced drug delivery strategy and platform for minimally-invasive treatment of liver cancer
#3889Compositions for Enhanced Absorption of Biologically Active Agents
#3890Preservation of bioactive materials by freeze dried foam
#3891Liquid vaccines for multiple meningococcal serogroups
#3892Method of Production of Fine-Crystalline Mixture Containing Non-Steroid Anti-Inflammatory Drug, Fine-Crystalline Mixture Obtainable by this Method and Solid Pharmaceutical Composition Containing this Mixture
#3893INTRAVESICAL APAZIQUONE ADMINISTRATION FOLLOWING TRANSURETHRAL RESECTION
#3894Marine algal extracts comprising marine algal polysaccharides of low degree polymerizaton, and the preparation processes and uses thereof
#3895STABLE POWDER FORMULATIONS OF ALUM-ADSORBED VACCINES
#3896Controlled release sterile injectable aripiprazole formulation and method
#3897ORGANIC COMPOUNDS
#3898Free-flowing lyophilized tobramycin formulation
#3899Lyophilized azithromycin formulation
#3900Aminoakyl methacrylate copolymer E for maintaining solubility of poorly-soluble drug